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Because Gibraltar’s macaques (Macaca sylvanus) have 
frequent contact with humans, we assayed 79 macaques for 
antibodies to enzootic primate viruses. All macaques were 
seronegative for herpesvirus B, simian T-cell lymphotropic 
virus, simian retrovirus, simian immunodeﬁ  ciency virus, and 
rhesus cytomegalovirus. Seroprevalence of simian foamy 
virus reached 88% among adult animals.
A
nimal reservoirs are the most likely sources of emerg-
ing infectious diseases that threaten human popula-
tions (1). Infectious agents from nonhuman primates, in 
particular, have caused a disproportionate number of new 
human diseases, leading to calls for international surveil-
lance to monitor the human–nonhuman primate interface. 
This recognition in turn prompts a need for data focusing 
on areas and contexts in which humans and nonhuman pri-
mates come into contact, creating the potential for zoonotic 
transmission (2,3).
Over the past decades, several viruses enzootic to 
nonhuman primates have been described, and a substantial 
amount of literature is devoted to their biology, genetics, 
and capacity to cause disease in humans. The most well 
known among these, in terms of public health, is simian im-
munodeﬁ  ciency virus (SIV), the progenitor of HIV. Other 
nonhuman primate–borne viruses with known or suspected 
links to human disease are simian T-cell lymphotropic vi-
rus (STLV) and herpesvirus B (Cercopithecine herpesvirus 
1) (CeHV-1).
Simian foamy virus (SFV) has received increasing at-
tention as recent ﬁ  ndings suggest that human contact with 
Asian macaques in a number of contexts leads to infection 
with this virus (2,4). All free-ranging macaque populations 
studied to date harbor SFV. Limited data on SFV in humans 
suggest that infection persists over time. In a small study of 
14 humans infected with SFV at primate research centers in 
the United States, 1 of 7 persons followed consistently over 
time was shown to have asymptomatic, nonprogressive, 
monoclonal natural killer cell lymphocytosis (5); however, 
no data link SFV infection with human disease. Further re-
search is needed to determine whether SFV causes immu-
nologic or hematologic effects in humans.
Europe’s only population of free-ranging nonhuman 
primates is found in the Upper Rock Nature Reserve in Gi-
braltar. These monkeys, also known as the Barbary ape, 
are macaques of the species Macaca sylvanus. When Gi-
braltar’s macaque population dwindled dangerously during 
World War II, the British government introduced M. syl-
vanus from Morocco and possibly Algeria to prevent local 
extinction. Over the past few decades, protection and pro-
visioning have led to a steady rise in the population, from 
≈30–50 to ≈240 currently.
In addition to their status as a unique wildlife heri-
tage, Gibraltar’s macaques are a boon for the local econ-
omy. On a typical day, taxi drivers and tour guides ferry 
thousands of visitors to the Upper Rock Reserve and often 
use food to entice monkeys to sit on the head or shoulders 
of visitors (Figure). Each year, >700,000 persons visit 
the reserve. In recent years, burgeoning macaque popula-
tions have become a nuisance for some Gibraltarians liv-
ing on the edges of the nature reserve, leading to selected 
culling.
Recent surveys of the Gibraltar macaques have de-
scribed 6 groups ranging in size from 14 to 64 individu-
als, with some overlap in range (6). Intensity and pattern 
of contact with humans vary by group; only 3 groups 
enter into areas visited regularly by tourists. In spite of 
extensive contact, aggressive interactions with humans 
are observed less frequently (on average, 170 persons/
year are treated for monkey-related injuries) in Gibraltar 
than in comparable contexts in Asia (7). Close human–
macaque contact has the potential to transmit infectious 
agents between the species (7,8). Given the large amount 
of interspecies contact occurring in Gibraltar, we sought 
to characterize the macaques’ potential as a reservoir for 
zoonotic disease.
The Study
We began an ongoing longitudinal serosurvey in 2004, 
sampling macaques from each of Gibraltar’s 6 groups for 
6 known enzootic nonhuman primate–borne viruses: SIV, 
CeHV-1, rhesus cytomegalovirus (RhCMV), STLV, SFV, 
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and simian retrovirus (SRV). Trapping, sampling, and as-
say protocols have been reported elsewhere (2,9–11).
As of 2007, a total of 79 animals were sampled (Table). 
None of the animals showed evidence of having been in-
fected with SIV, SRV, an alphaherpesvirus antigenically 
related to CeHV-1, STLV, or with a CMV antigenically 
related to RhCMV. The complete absence of seroreactiv-
ity to CeHV-1 and RhCMV by ELISA was particularly 
striking because both viruses are considered enzootic in 
populations of wild-caught and captive macaques (9,13). 
In contrast, more than half of the population showed evi-
dence of infection with SFV (Table). Prevalence of SFV 
infection increased with age, from 20% among young 
juveniles to ≈90% among adults. No differences in SFV 
antibody prevalence were detected between male and fe-
male macaques or among the 6 groups. Eight macaques 
were sampled at 2 periods during the study. None of the 
5 initially SFV-seronegative macaques had seroconverted 
by the second sampling. Similarly, all 3 of the initially 
SFV-seropositive macaques remained seropositive at sec-
ond sampling.
Conclusions
The Gibraltar macaques are serologically unique. 
The population shows no evidence of infection with ei-
ther CeHV-1 or RhCMV, in contrast to other macaque 
populations studied in which animals seroconvert early 
in life (14). Both these viruses are old viruses that are 
thought to have coevolved with nonhuman primate spe-
cies over millions of years. One possible explanation for 
the lack of CeHV-1 and RhCMV in this population is that 
the M. sylvanus populations in North Africa from which 
they were derived are not infected with these viruses. At 
present, the prevalence of these 2 viruses among North 
African macaques is unknown. If North African M syl-
vanus are infected with CeHV-1 and RhCMV, our results 
could be explained by a founder effect or the loss of ge-
netic variation when a new colony is established by a very 
small number of individuals from a larger population. Be-
cause seroconversion begins early in life, this hypothesis 
would imply that the progenitors of the present popula-
tion were translocated from North Africa when they were 
young, likely <1 year of age, and therefore less likely to be 
infected with the viruses.
SFV seroprevalence in Gibraltar macaques mirrors 
that of other studied macaque populations in South and 
Southeast Asia with the exception that they seroconvert to 
SFV at a later age. For example, 81% of free-ranging ma-
caques in Thailand are SFV positive by the age of 3 years, 
compared with only 38.7% of Gibraltar macaques (15). 
This observation could be explained by decreased rates of 
aggression because bites are thought to be a principal mode 
of virus transmission. Properties of the virus or physiologic 
or immunologic characteristics of the macaques could also 
inﬂ  uence virus transmission.
The relatively low rates of interspecies aggression 
observed between macaques and humans in Gibraltar and 
the low seroprevalence of enzootic nonhuman primate vi-
ruses detected in this serosurvey suggest that the risk for 
virus transmission from macaques to humans in Gibraltar is 
lower than this risk in other locations where humans come 
into contact with free-ranging macaques. Nevertheless, the 
abundance of contact between humans and macaques in 
Gibraltar implies that the possibility of bidirectional cross-
species transmission of infectious agents, including SFV, 
remains and has implications for humans and macaques. 
This prospect justiﬁ  es continued vigilance by local park au-
thorities to monitor and regulate contact between humans 
and macaques at the Upper Rock Reserve. We recommend 
strengthened efforts to discourage tourists and locals from 
feeding macaques and strict enforcement of rules enjoining 
visitors from seeking contact with them. Macaques should 
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Figure. A) Each year >700,000 tourists visit Gibraltar’s Upper Rock 
Reserve, contributing millions of dollars to the local economy. 
B) Tourists ﬁ  nd Gibraltar’ macaques compelling. C) Tour guides use 
food to entice macaques to perch on visitors, potentially exposing 
the visitors’ mucous membranes to macaque body ﬂ  uids, a potential 
route for cross-species transmission of enzootic macaque viruses.be fed exclusively in designated areas by trained park per-
sonnel; such feeding should compensate for decreased feed-
ing by the general public. Finally, water supplies should be 
enhanced at feeding sites. These changes will preserve the 
public’s ability to observe the macaques while simultane-
ously reducing the risk for cross-species transmission of 
infectious agents.
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Table. Seroprevalence of enzootic simian viruses in macaques, Gibraltar, 2004–2007 
Seroprevalence, % (no. positive/no. tested) 
Category No. (%)  SFV* SIV† SRV† CeHV-1† STLV† RhCMV‡
Sex
  Male  45 (57.0)  57.8 (26/45)  0.0 0.0 0.0 0.0 0.0
  Female  34 (43.0)  52.9 (18/34)  0.0 0.0 0.0 0.0 0.0
Age class§
  Young juvenile  10 (12.7)  20.0 (2/10)  0.0 0.0 0.0 0.0 0.0
  Older juvenile  31 (39.2)  38.7 (12/31)  0.0 0.0 0.0 0.0 0.0
  Subadult  13 (16.5)  61.5 (8/13)  0.0 0.0 0.0 0.0 0.0
  Adult  25 (31.6)  88.0 (22/25)  0.0 0.0 0.0 0.0 0.0
Total 79 55.7 (44/79)  0.0 0.0 0.0 0.0 0.0
*Simian foamy virus (SFV) seroprevalence for 2004 samples determined using enzyme immunoassay. Subsequent samples screened as part of the 
whole-virus multiplex flow cytometric assay (11).
†Simian immunodeficiency virus (SIV), simian retrovirus (SRV), Cercopithecine herpesvirus 1 (CeHV-1), simian T-cell lymphotropic virus (STLV) 
seroprevalence for 2004 samples determined by using multiplex microbead assay (10); seroprevalence for subsequent samples determined by using 
whole-virus multiplex flow cytometric assay (11).
‡Rhesus cytomegalovirus (RhCMV) seroprevalence for the 2004 samples (n = 40) determined by ELISA according to previously published protocols (12).
Subsequent samples not screened. 
§Age class determinations made on the basis of dental eruption sequence and morphometrics: young juvenile, <1 y of age; older juvenile, 1–3 y; 
subadult, 3–5 y; adult, >5 y. Enzootic Primate Viruses in Gibraltar Macaques
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